REFERENCES
1. González-Vidal T, Rivas-Otero D, Gutiérrez-Hurtado A, et al. Hypoglycemia in patients with type 2 diabetes mellitus during hospitalization: associated factors and prognostic value. Diabetol Metab Syndr. 2023;15:249.
2. Heller SR, Peyrot M, Oates SK, Taylor AD. Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen. BMJ Open Diabetes Res Care. 2020;8:e001194.
3. Wang Y, Liu H, Hu X, et al. Association between hemoglobin glycation index and 5-year major adverse cardiovascular events: the REACTION cohort study. Chin Med J. 2023;136:2468-75.
4. Pan L, Lu F, Cheng B, Zhang W, Wang B. Association between hemoglobin glycation index and mortality in critically ill patients: a retrospective cohort study. J Health Popul Nutr. 2025;44:249.
5. Zhao M, Sun N, Cheng Y, et al. Hemoglobin glycation index and mortality risk in metabolic dysfunction-associated steatotic liver disease patients: a novel U-shaped association. Sci Rep. 2025;15:1465.
6. Hempe JM, Liu S, Myers L, McCarter RJ, Buse JB, Fonseca V. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care. 2015;38:1067-74.
7. Shi F, Yang Z, Wang Z, Wang L, Fang C. Association of hemoglobin glycation index with all-cause and cardiovascular mortality in patients with diabetes or prediabetes and comorbid cardiovascular disease: a population-based cohort study. Sci Rep. 2025;15:20696.
8. Ernesti I, Massari MC, Cipriani F, et al. Impact of a very low-calorie ketogenic diet on metabolic and microbiota outcomes in post-bariatric patients and bariatric-Naïve individuals: a comparative pilot study. Diabetes Obes Metab. 2025;27:1950-9.
9. Wongwananuruk T, Prasongvej P, Chantrapanichkul P, et al. Measures of serum markers HbA1c, HOMA-IR, HOMA-β, QUICKI and G/I Ratio as predictors of abnormal glucose tolerance among thai women with polycystic ovary syndrome. J Clin Med. 2025;14:1452.
10. Ning G, Bloomgarden Z. Diabetes and cancer: findings from the REACTION study: REACTION. J Diabetes. 2015;7:143-4.
11. American Diabetes Association Professional Practice Committee. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45:S17-38.
12. Solnica B, Sygitowicz G, Sitkiewicz D, et al. 2024 Guidelines of the Polish Society of Laboratory Diagnostics and the Polish Lipid Association on laboratory diagnostics of lipid metabolism disorders. Arch Med Sci. 2024;20:357-74.
13. Hitz MP, Dombrowsky G, Melnik N, Vey C. Current and future diagnostics of congenital heart disease (CHD). Med Genet. 2025;37:95-102.
14. Tu Q, Lin S, Hafiz N, et al. Independent and joint associations of hypertension and depression with cardiovascular diseases and all-cause mortality: a population-based cohort study. J Hum Hypertens. 2025;Epub ahead of print.
15. Hayes AF. An index and test of linear moderated mediation. Multivariate Behav Res. 2015;50:1-22.
16. Hempe JM, Hsia DS. Variation in the hemoglobin glycation index. J Diabetes Complications. 2022;36:108223.
17. Hempe JM, Yang S, Liu S, Hsia DS. Standardizing the haemoglobin glycation index. Endocrinol Diabetes Metab. 2021;4:e00299.
18. Hempe JM, Gomez R, McCarter RJ Jr, Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications. 2002;16:313-20.
19. Ghazaiean M, Najafi B, Zamanfar D, Alipour MJ. Risk factors for suboptimal glycemic control in pediatrics with type 1 diabetes mellitus: a cross-sectional study. Sci Rep. 2024;14:7492.
20. Klein KR, Franek E, Marso S, et al. Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE. BMJ Open Diabetes Res Care. 2021;9:e002339.
21. Lin BS, Liu ZG, Chen DR, et al. Relationship between hemoglobin glycation index and risk of hypoglycemia in type 2 diabetes with time-in-range in target. World J Diabetes. 2024;15:2058-69.
22. Lipska KJ, Warton EM, Huang ES, et al. HbA1c and risk of severe hypoglycemia in type 2 diabetes: the diabetes and aging study. Diabetes Care. 2013;36:3535-42.
23. Zhong VW, Juhaeri J, Cole SR, et al. Proximal HbA1C level and first hypoglycemia hospitalization in adults with incident type 2 diabetes. J Clin Endocrinol Metab. 2019;104:1989-98.
24. Li J, Guo K, Zhang L, et al. Individualized coefficient of variability cut-off values for reducing the risk of hypoglycemia in Chinese type 1 diabetes mellitus (T1DM) patients. Chin Med J. 2024;137:244-6.
25. Shabestari M, Mehrabbeik A, Barbieri S, Marques-Vidal P, Heshmati-Nasab P, Azizi R. Predictive factors of hypoglycemia in type 2 diabetes: a prospective study using machine learning. Sci Rep. 2025;15:18143.
26. Min Ko M, Kit Lee W, Chang Ang L, Goh SY, Mong Bee Y, Ming Teh M. A Cross-Sectional study on risk factors for severe hypoglycemia among Insulin-Treated elderly type 2 diabetes Mellitus (T2DM) patients in Singapore. Diabetes Res Clin Pract. 2022;185:109236.
27. Jiang J, Cai X, Pan Y, et al. Relationship of obesity to adipose tissue insulin resistance. BMJ Open Diabetes Res Care. 2020;8:e000741.
